Richard Bucala, MD, PhD

DWnews TV Interview with Dr. Richard Bucala | 25th April | topic: World Malaria Day @YaleRheumAller1 @YaleIMed share.ard-zdf-box.de/s/DpWRXw9PqWQ5…

Yale School of Medicine Is in the Top Ten in Latest U.S. News Rankings m.yale.edu/cfd7 via @yalemed

How mRNA Technology Could Change the World @YaleRheumAller1 theatlantic.com/ideas/archive/…

Meet Handsome Dan XIX news.yale.edu/2021/03/18/mee…

Aging with HIV in Latin America and the Caribbean: a Systematic Review by Dr. Evelyn Hsieh from @YaleRheumAller1 @YaleIMed pubmed.ncbi.nlm.nih.gov/33400168/

The ACR recently released #COVID19 #vaccine guidance & has submitted letters to state leaders urging them to prioritize patients on immunosuppressants in accordance with ACR recommendations. Help us amplify our message → acr.tw/3t1dIV6

A vaccine against malaria: five minutes with . . . Richard Bucala bmj.com/content/bmj/37…

Can RNA Create a Malaria Vaccine? freethink.com/articles/malar…

Editor's Pick from the March 2021 Arthritis & Rheumatology: Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry by @MilenaGianfran @rheum_covid onlinelibrary.wiley.com/doi/full/10.10…

Apparently someone told @GovNedLamont the pandemic was over and not to worry about placing countless lives at risk. courant.com/coronavirus/hc…

Malaria is notoriously hard to vaccinate against. A new vaccine technology might change that. vox.com/future-perfect… via @voxdotcom

'A Malaria Vaccine Candidate blogs.sciencemag.org/pipeline/archi…

Join LRA March 11 to Learn What’s New in Lupus Nephritis featuring Dr. Fotios Koumpouras from @YaleRheumAller1 @YaleIMed : lupusresearch.org/join-lra-march…

First vaccine to fully immunize against malaria builds on pandemic-driven RNA tech academictimes.com/first-vaccine-… via @academictimes

Breakthrough made in vaccine against malaria using same tech for COVID-19 @YaleIMed @YaleRheumAller1 @BucalaRichard i24news.tv/en/news/techno…